应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AMLX Amylyx Pharmaceuticals
盘前交易 04-14 05:13:09 EDT
3.65
+0.16
+4.58%
最高
3.68
最低
3.42
成交量
56.24万
今开
3.49
昨收
3.49
日振幅
7.31%
总市值
3.23亿
流通市值
2.15亿
总股本
8,860万
成交额
201.17万
换手率
0.95%
流通股本
5,896万
市净率
1.96
ROE
-100.88%
每股收益
-4.43
52周最高
7.27
52周最低
1.58
市盈率
-0.82
股息
1.35
股息收益率
0.37
ROA
-51.31%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.13%报3.67美元
市场透视 · 04-11 17:53
Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.13%报3.67美元
Amylyx Pharma 第四季度每股收益$(0.55) 未达到预期$(0.52)
财报速递 · 03-04
Amylyx Pharma 第四季度每股收益$(0.55) 未达到预期$(0.52)
Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.02%
市场透视 · 2024-12-03
Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.02%
Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.05%
市场透视 · 2024-11-26
Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.05%
Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.31%报5.55美元
市场透视 · 2024-11-25
Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.31%报5.55美元
Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨15.13%
市场透视 · 2024-11-18
Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨15.13%
Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.37%
市场透视 · 2024-11-14
Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.37%
Amylyx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.29%
市场透视 · 2024-11-13
Amylyx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.29%
Amylyx Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.00%
市场透视 · 2024-11-11
Amylyx Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.00%
Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.01%
市场透视 · 2024-11-08
Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.01%
Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.00%
市场透视 · 2024-11-01
Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.00%
Amylyx Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.06%报5.58美元
市场透视 · 2024-10-28
Amylyx Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.06%报5.58美元
Amylyx Pharmaceuticals, Inc.盘中异动 快速拉升5.00%报5.15美元
市场透视 · 2024-10-25
Amylyx Pharmaceuticals, Inc.盘中异动 快速拉升5.00%报5.15美元
Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨9.30%
市场透视 · 2024-10-23
Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨9.30%
Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.23%报5.03美元
市场透视 · 2024-10-21
Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.23%报5.03美元
Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.03%
市场透视 · 2024-10-15
Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.03%
Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.03%
市场透视 · 2024-10-08
Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.03%
Amylyx Pharmaceuticals, Inc.盘中异动 临近午盘快速上涨5.07%报3.09美元
市场透视 · 2024-10-04
Amylyx Pharmaceuticals, Inc.盘中异动 临近午盘快速上涨5.07%报3.09美元
Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.03%报3.03美元
市场透视 · 2024-09-20
Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.03%报3.03美元
加载更多
公司概况
公司名称:
Amylyx Pharmaceuticals
所属市场:
NASDAQ
上市日期:
2022-01-07
主营业务:
Amylyx Pharmaceuticals, Inc.于2014年1月10日根据特拉华州法律成立。该公司是一家临床阶段的制药公司,其使命是为医疗需求未得到满足的社区开发和推进新疗法。该公司在神经退行性疾病和内分泌疾病方面正在进行临床前和临床开发项目。该公司正在推进一项管道,在该管道中,该公司已将研究性疗法与认为这些疗法可以产生最大影响的疾病相匹配,基于明确定义的机制原理、明确的临床结果和生物标志物,以及严格的临床前数据,与模式无关。
发行价格:
19.00
{"stockData":{"symbol":"AMLX","market":"US","secType":"STK","nameCN":"Amylyx Pharmaceuticals","latestPrice":3.65,"timestamp":1744401600000,"preClose":3.49,"halted":0,"volume":562445,"delay":0,"floatShares":58959900,"shares":88602468,"eps":-4.43,"marketStatus":"盘前交易","change":0.16,"latestTime":"04-14 05:13:07 EDT","open":3.49,"high":3.675,"low":3.42,"amount":2011744.1081465,"amplitude":0.073066,"askPrice":4.1,"askSize":100,"bidPrice":1.46,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-4.43,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1744637400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1641531600000,"exchange":"NASDAQ","adjPreClose":3.65,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":3.67,"preClose":3.65,"latestTime":"19:42 EDT","volume":6513,"amount":23772.27,"timestamp":1744414948110},"volumeRatio":0.6733350715571973,"impliedVol":0.7319,"impliedVolPercentile":0.324},"requestUrl":"/m/hq/s/AMLX","defaultTab":"news","newsList":[{"id":"2526197466","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.13%报3.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526197466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2526197466?lang=zh_cn&edition=full","pubTime":"2025-04-12 01:53","pubTimestamp":1744394003,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时53分,Amylyx Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.13%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.87%。其相关个股中,Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大,Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为2122.12%、1676.84%、400.17%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.,振幅分别为193.75%、156.27%、77.44%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司,致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041201532497359435&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041201532497359435&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"1106700622","title":"Amylyx Pharma 第四季度每股收益$(0.55) 未达到预期$(0.52)","url":"https://stock-news.laohu8.com/highlight/detail?id=1106700622","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106700622?lang=zh_cn&edition=full","pubTime":"2025-03-04 19:14","pubTimestamp":1741086875,"startTime":"0","endTime":"0","summary":"Amylyx Pharma报告季度每股亏损$,低于分析师共识预期的$,低了5.77%。相比去年同期每股收益$0.07,这一结果下降了885.71%。以上内容来自Benzinga Earnings专栏,原文如下:Amylyx Pharma reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 5.77 percent. This is a 885.71 percent decrease over earnings of $0.07 per share from the same period last year. The company reported $ in sales this quarter. This is a 100.61 percent decrease over sales of $108.45 million the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Amylyx Pharma 第四季度每股收益$(0.55) 未达到预期$(0.52)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX"],"gpt_icon":0},{"id":"2488944791","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488944791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488944791?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:16","pubTimestamp":1733238980,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时16分,Amylyx Pharmaceuticals, Inc.股票出现异动,股价急速下跌5.02%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.48%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203231620a269acce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203231620a269acce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2486002790","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486002790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486002790?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:11","pubTimestamp":1732633860,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时11分,Amylyx Pharmaceuticals, Inc.股票出现异动,股价快速跳水5.05%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.37%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623110098e44b1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623110098e44b1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2486308028","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.31%报5.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486308028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486308028?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545224,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时33分,Amylyx Pharmaceuticals, Inc.股票出现异动,股价急速拉升5.31%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.06%。其相关个股中,Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、Citius Pharmaceuticals, Inc.涨幅较大,Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃,换手率分别为87.20%、61.57%、38.68%,振幅较大的相关个股有Anixa Biosciences, Inc.、Werewolf Therapeutics, Inc.、Kodiak Sciences Inc,振幅分别为105.47%、105.26%、105.01%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522334998e4465d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522334998e4465d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2484326676","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨15.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484326676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484326676?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:33","pubTimestamp":1731940389,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时33分,Amylyx Pharmaceuticals, Inc.股票出现波动,股价快速上涨15.13%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.15%。其相关个股中,Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大,Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃,换手率分别为517.53%、210.81%、189.81%,振幅较大的相关个股有Hcw Biologics Inc.、Fate Therapeutics, Inc.、冠科美博,振幅分别为50.92%、35.15%、34.31%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822330995be488b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822330995be488b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2483802205","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483802205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483802205?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:30","pubTimestamp":1731594656,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时30分,Amylyx Pharmaceuticals, Inc.股票出现异动,股价大幅跳水5.37%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223056971a68b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223056971a68b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2483598568","title":"Amylyx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483598568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483598568?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:17","pubTimestamp":1731525429,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时17分,Amylyx Pharmaceuticals, Inc.股票出现波动,股价大幅跳水5.29%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大,Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为549.55%、486.87%、153.44%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、Celularity Inc C/Wts 16/07/2026 ,振幅分别为132.00%、86.83%、73.71%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114031709abbe6aa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114031709abbe6aa8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2482684607","title":"Amylyx Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482684607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482684607?lang=zh_cn&edition=full","pubTime":"2024-11-12 04:40","pubTimestamp":1731357650,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日04时40分,Amylyx Pharmaceuticals, Inc.股票出现波动,股价快速上涨5.00%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.81%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111204405098e41e10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111204405098e41e10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2481100850","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481100850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481100850?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:45","pubTimestamp":1731077139,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时45分,Amylyx Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.01%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.51%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224539abae44e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224539abae44e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2480887926","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480887926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2480887926?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:25","pubTimestamp":1730471139,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时25分,Amylyx Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.00%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.81%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101222539971a3e18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101222539971a3e18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2478648441","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.06%报5.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478648441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2478648441?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:22","pubTimestamp":1730125328,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时22分,Amylyx Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.06%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.59%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822220898e3ed93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822220898e3ed93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2478959164","title":"Amylyx Pharmaceuticals, Inc.盘中异动 快速拉升5.00%报5.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478959164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2478959164?lang=zh_cn&edition=full","pubTime":"2024-10-26 00:49","pubTimestamp":1729874969,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日00时49分,Amylyx Pharmaceuticals, Inc.股票出现波动,股价大幅上涨5.00%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.74%。其相关个股中,Iterum Therapeutics Plc、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Immunitybio, Inc.涨幅较大,180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃,换手率分别为834.34%、759.26%、287.94%,振幅较大的相关个股有Iterum Therapeutics Plc、Qualigen Therapeutics, Inc.、Elevai Labs, Inc.,振幅分别为102.56%、91.58%、89.80%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026004929ab7467ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026004929ab7467ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2477489538","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨9.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477489538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2477489538?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:31","pubTimestamp":1729690277,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时31分,Amylyx Pharmaceuticals, Inc.股票出现异动,股价急速上涨9.30%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321311895bd4294&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321311895bd4294&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2477863731","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.23%报5.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477863731","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2477863731?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:34","pubTimestamp":1729517684,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时34分,Amylyx Pharmaceuticals, Inc.股票出现波动,股价大幅上涨5.23%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.04%。其相关个股中,Biovie Inc.、Werewolf Therapeutics, Inc.、Genprex, Inc.涨幅较大,Genprex, Inc.、Biovie Inc.、Windtree Therapeutics, Inc.较为活跃,换手率分别为635.20%、372.16%、219.40%,振幅较大的相关个股有Biovie Inc.、Celularity Inc C/Wts 16/07/2026 、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为44.26%、39.86%、35.04%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213445971a15cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213445971a15cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2475075686","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475075686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2475075686?lang=zh_cn&edition=full","pubTime":"2024-10-15 21:48","pubTimestamp":1729000090,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日21时48分,Amylyx Pharmaceuticals, Inc.股票出现波动,股价急速上涨5.03%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.09%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015214811ab6a45d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015214811ab6a45d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2474470275","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474470275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2474470275?lang=zh_cn&edition=full","pubTime":"2024-10-09 00:03","pubTimestamp":1728403398,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日00时03分,Amylyx Pharmaceuticals, Inc.股票出现异动,股价急速拉升5.03%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.28%。其相关个股中,Bio-Path Holdings, Inc.、Portage Biotech Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大,Aditxt, Inc.、Bio-Path Holdings, Inc.、Gri Bio, Inc.较为活跃,换手率分别为2440.48%、2313.14%、250.19%,振幅较大的相关个股有Virios Therapeutics, Inc.、Trevena, Inc.、Bio-Path Holdings, Inc.,振幅分别为46.27%、42.80%、39.93%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009000319a1df1383&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009000319a1df1383&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2473961012","title":"Amylyx Pharmaceuticals, Inc.盘中异动 临近午盘快速上涨5.07%报3.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473961012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2473961012?lang=zh_cn&edition=full","pubTime":"2024-10-04 23:52","pubTimestamp":1728057126,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日23时52分,Amylyx Pharmaceuticals, Inc.股票出现波动,股价急速上涨5.07%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.40%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004235206ab67c03a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004235206ab67c03a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2468621680","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.03%报3.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468621680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2468621680?lang=zh_cn&edition=full","pubTime":"2024-09-20 22:01","pubTimestamp":1726840871,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日22时01分,Amylyx Pharmaceuticals, Inc.股票出现波动,股价快速上涨5.03%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.50%。Amylyx Pharmaceuticals, Inc.公司简介:Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司,致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920220111a1db7532&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920220111a1db7532&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amylyx.com","stockEarnings":[{"period":"1week","weight":0.0641},{"period":"1month","weight":-0.0665},{"period":"3month","weight":0.0429},{"period":"6month","weight":0.0282},{"period":"1year","weight":0.5939},{"period":"ytd","weight":-0.0344}],"compareEarnings":[{"period":"1week","weight":0.0567},{"period":"1month","weight":-0.0446},{"period":"3month","weight":-0.0802},{"period":"6month","weight":-0.0787},{"period":"1year","weight":0.0308},{"period":"ytd","weight":-0.089}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Amylyx Pharmaceuticals, Inc.于2014年1月10日根据特拉华州法律成立。该公司是一家临床阶段的制药公司,其使命是为医疗需求未得到满足的社区开发和推进新疗法。该公司在神经退行性疾病和内分泌疾病方面正在进行临床前和临床开发项目。该公司正在推进一项管道,在该管道中,该公司已将研究性疗法与认为这些疗法可以产生最大影响的疾病相匹配,基于明确定义的机制原理、明确的临床结果和生物标志物,以及严格的临床前数据,与模式无关。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.037729},{"month":2,"riseRate":0.5,"avgChangeRate":0.096144},{"month":3,"riseRate":0.25,"avgChangeRate":-0.384218},{"month":4,"riseRate":0.25,"avgChangeRate":-0.165813},{"month":5,"riseRate":0,"avgChangeRate":-0.064193},{"month":6,"riseRate":0.666667,"avgChangeRate":0.381588},{"month":7,"riseRate":1,"avgChangeRate":0.190906},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.022589},{"month":9,"riseRate":0.666667,"avgChangeRate":0.141337},{"month":10,"riseRate":0.666667,"avgChangeRate":0.274859},{"month":11,"riseRate":0.666667,"avgChangeRate":-0.010067},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.10505}],"exchange":"NASDAQ","name":"Amylyx Pharmaceuticals","nameEN":"Amylyx Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.0","shortVersion":"4.33.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amylyx Pharmaceuticals(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Amylyx Pharmaceuticals(AMLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Amylyx Pharmaceuticals,AMLX,Amylyx Pharmaceuticals股票,Amylyx Pharmaceuticals股票老虎,Amylyx Pharmaceuticals股票老虎国际,Amylyx Pharmaceuticals行情,Amylyx Pharmaceuticals股票行情,Amylyx Pharmaceuticals股价,Amylyx Pharmaceuticals股市,Amylyx Pharmaceuticals股票价格,Amylyx Pharmaceuticals股票交易,Amylyx Pharmaceuticals股票购买,Amylyx Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amylyx Pharmaceuticals(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Amylyx Pharmaceuticals(AMLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}